Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Azurity Pharmaceuticals, Inc. v. Alkem Laboratories Ltd.
Case Number:
1:19-cv-02100
Court:
Nature of Suit:
Patent - Abbreviated New Drug Application(ANDA)
Judge:
Firms
Companies
Sectors & Industries:
-
February 13, 2023
Azurity Loses Hypertension Drug Patent Trial Against Alkem
A federal judge sitting in Delaware ruled Friday that several claims of two patents on Azurity Pharmaceuticals Inc.'s hypertension drug Epaned are invalid, handing a win to Alkem Laboratories Ltd., which is planning a generic version of the drug.
-
August 11, 2022
IP Forecast: Tesla Wants To Steer Secrets Case Out Of Court
Tesla will tell a California federal judge next week that an employment agreement now warrants arbitration of its trade secrets case against an engineer who helped develop a supercomputer powering the company's self-driving cars. Here's a look at that case — plus all the other major intellectual property matters on deck in the coming week.